An overview of the Program & LESI’s role/goals facilitating these conversations. This session discussed upcoming topics focused on what licensees need to know about SEP negotiations.
Litigation and enforcement actions; focus on what both sides need to know when negotiating SEPs.
This panel with dig into the various policy discussions around the Draft EU SEP regulations as well as US legislative proposals addressing SEPs – what is being proposed and what is the timeline, what is the appropriate role of government in these discussions.
An overview of the Program & LESI’s role/goals facilitating these conversations. This session will discuss topics that will be addressed in this track during the year related to AI in the Life Sciences industry — from specific uses such as drug discovery, clinical trials, medical devices to regulatory, IP and data related legal requirements and challenges.
Examples of who AI is used for drug discovery & clinical trials + IP regulatory challenges.
An overview of the Thought Leadership Program & LESI’s role/goals facilitating these conversations. In this first session, Sam Wiley of the LOT Network will interview Tillman Mueller-Stoy on his experience litigating the first case heard by the Unified Patent Court (UPC) and the considerations that went into his effective planning.
Examples of who AI is used for drug discovery & clinical trials + IP regulatory challenges.
These events are only open to current LES members. If you are not currently a member of a local LES Society, we encourage you to join your local LES society! If you are not ready to join LES, you can purchase a package for the LESI Thought Leadership Program (all three tracks) for $150 USD. Please contact the LESI Admin Office at NNE@lesi.org to register for this package.
Login
